8-K: Pro-Dex Reports Record Q3 Revenue and APM Acquisition

Pro-Dex, Inc. achieved record quarterly revenue of $19.9 million for Q3 2026, driven by strong orthopedic handpiece shipments.

Summary

• Net sales for the third quarter ended March 31, 2026, reached a record $19.9 million, a 15% increase year-over-year.
• Net income for the quarter was $3.9 million, or $1.20 per diluted share, compared to $3.3 million, or $0.98 per diluted share, in the prior year.
• Nine-month net sales grew 16% to $57.1 million.
• The company completed the acquisition of Advanced Precision Machining, LLC (APM) during the quarter.
• Quarterly results include a $2.3 million realized gain from contingent value rights related to Monogram Technologies, Inc.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report due to record revenue and strategic expansion, though tempered by margin compression and high customer concentration.

Positives

• Record quarterly revenue of $19.9 million.
• 15% year-over-year growth in quarterly net sales.
• Successful completion of the APM acquisition, expanding machining capacity and technology.
• Strong net income growth to $3.9 million for the quarter.
• Increased shipments of next-generation orthopedic handpieces.

Negatives

• Gross margin decreased by 2 percentage points to 31% for the quarter due to unfavorable product mix.
• Operating expenses increased by 41% to $3.0 million, driven by acquisition costs and higher personnel expenses.
• Operating income for the quarter declined 15% to $3.1 million.
• Repair revenue from the largest customer decreased by $2.4 million during the quarter.

Risks

• Reliance on a single largest customer for a significant portion of revenue.
• Potential for continued unfavorable product mix impacting gross margins.
• Integration risks associated with the newly acquired APM subsidiary.
• Fluctuations in non-tradeable contingent value rights and equity investments impacting net income.

Future Outlook

Management states the company is well-positioned for sustained success for the remainder of the fiscal year and beyond, leveraging the new revenue streams and capacity from the APM acquisition.

Management Comments

• Our third quarter revenue reflects a new quarterly record.
• We remain excited about both the additional revenue streams created as well as the expanded machining capacity and technology provided by this subsidiary (APM).
• We are well positioned for sustained success for the remainder of this fiscal year and beyond.

Industry Context

StockSavvy.ai notes that Pro-Dex is navigating a transition toward next-generation orthopedic technology while managing the integration of precision machining capabilities, a common trend among medical device contract manufacturers seeking vertical integration to protect margins.

Comparison to Industry Standards

• Revenue growth of 15% outperforms many mid-cap medical device component manufacturers.
• Gross margins of 30-31% are consistent with specialized medical device manufacturing but remain sensitive to product mix shifts.
• The reliance on a single major customer remains a higher concentration risk compared to diversified industry peers.

Stakeholder Impact

• Shareholders benefit from record revenue and earnings growth.
• Customers gain from expanded machining capacity via the APM acquisition.

Next Steps

• Integration of Advanced Precision Machining, LLC (APM) operations.
• Continued focus on next-generation orthopedic handpiece production.

Key Dates

Recommendation

While the company shows strong growth and strategic expansion, the high customer concentration and margin pressure suggest a cautious approach until the APM acquisition is fully integrated and margin stability is demonstrated.

Keywords

Pro-Dex, PDEX, orthopedic devices, surgical drivers, medical manufacturing, APM acquisition, surgical shavers